GO
Loading...

Enter multiple symbols separated by commas

Health Care Biotech and Pharmaceuticals

More

  • Golden age of heart valve treatment: EW CEO Friday, 29 May 2015 | 7:36 AM ET
    Golden age of heart valve treatment: EW CEO

    Michael Mussallem, Edwards Lifesciences CEO, provides insight into the future of treating heart disease.

  • Pulse of heart valve technology: EW CEO Friday, 29 May 2015 | 7:33 AM ET
    Pulse of heart valve technology: EW CEO

    Michael Mussallem, Edwards Lifesciences CEO, discusses major strides the medical community has made in cardiovascular treatment.

  • Cellectis jumps 14% on talks of sale to Pfizer Thursday, 28 May 2015 | 3:57 PM ET
    French CEO of Cellectis, a biotechnology company, Andre Choulika.

    Pfizer reportedly approached Cellectis with a deal that could value it at about $1.64 billion, the Financial Times reported.

  • Biotech investors up big amid bubble talk Thursday, 28 May 2015 | 9:56 AM ET
    Biotech

    Some view skyrocketing biotech stocks as a bubble, but hedge funds are riding optimism in the sector to monster gains—for now.

  • Paying for a shakeup in cancer drugs Wednesday, 27 May 2015 | 3:48 PM ET
    Paying for cancer drug performance

    A major drug prescription benefits manager is pushing to change the skyrocketing pricing structure, reports CNBC's Meg Tirrell

  • Linking cancer drug prices to their performance Wednesday, 27 May 2015 | 1:54 PM ET

    Express Scripts is looking at the possibility of paying more for drugs that have been proven to show more benefit, and less where the drug hasn't.

  • One trader’s very contrarian pharma trade Wednesday, 27 May 2015 | 10:22 AM ET

    Cowen's David Seaburg has a very interesting way to play biotech and pharma stocks now.

  • Actavis hard switch Friday, 22 May 2015 | 2:30 PM ET
    Actavis hard switch

    A federal appeals court has made a ruling on a top selling Alzheimer's drug that could make things difficult for drugmaker Actavis, reports CNBC's Meg Tirrell.

  • This is the next big thing according to Mark Cuban Wednesday, 20 May 2015 | 5:12 PM ET
    Marc Cuban

    Mark Cuban said innovative tech in the pharmaceutical sector is going to be a game changer not only for health care, but for humanity.

  • J&J can weather new biotech threat: Analyst Wednesday, 20 May 2015 | 4:33 PM ET
    Johnson & Johnson

    Cheaper biotech drugs are headed to the U.S., but analyst Mike Weinstein thinks J&J can manage through some of the challenges.

  • How biotechs are affecting J&J's business Wednesday, 20 May 2015 | 1:55 PM ET
    How biotechs are affecting J&J's business

    Michael Weinstein, JPM, managing director of healthcare, joins CNBC's Meg Tirrell to discuss biosimilar, the threat to big pharmaceuticals, and how Johnson & Johnson will be affected.

  • Scientists experiment to make old brains new again Wednesday, 20 May 2015 | 11:34 AM ET
    Mice in science lab

    Researchers at UC Irvine restored a key feature of young brains, the flexibility that allows for learning and creativity.

  • J&J: 10 new drugs by 2019, each with $1B potential Wednesday, 20 May 2015 | 9:11 AM ET
    Johnson & Johnson's Janssen Labs in La Jolla, California.

    "You're going to have some wins and some that don't turn out," J&J chief Alex Gorsky tells CNBC. "But overall we're very confident."

  • Gene therapy's promise and hope for the blind: ONCE CEO

    Jeffrey Marrazzo, Spark Therapeutics CEO, and Dr. Jean Bennett, Spark Therapeutics advisor, discuss how advances in gene therapy are changing the way rare diseases are treated. And Gordon Gund, Gund Investment Corp. CEO, weighs in.

  • Cancer data deluge Thursday, 14 May 2015 | 2:32 PM ET
    Cancer data deluge

    CNBC's Meg Tirrell breaks down all the biotech data coming out ahead of the ASCO Conference, and why Clovis Oncology's stock is climbing.

  • Viagra may help cure malaria Thursday, 14 May 2015 | 11:31 AM ET
    Viagra pill

    A new study suggests Viagra can fight malaria, which still infects millions and kills half a million people every year.

  • Bill Nye Kickstarts solar-powered space travel Thursday, 14 May 2015 | 10:49 AM ET
    A depiction of LightSail with its unfurled solar sails

    U.S. scientist Bill Nye, popularly known as "the Science Guy", has launched a Kickstarter to fund an satellite propelled by solar energy.

  • ASCO's immunotherapies update Thursday, 14 May 2015 | 6:19 AM ET
    ASCO's immunotherapies update

    CNBC's Meg Tirrell takes a look at new cancer-fighting drugs and other therapies in the pipeline.

  • Biotech to watch ahead of ASCO Wednesday, 13 May 2015 | 2:36 PM ET
    Biotech to watch ahead of ASCO

    The American Society of Clinical Oncology conference will occur at the end of May in Chicago. CNBC's Meg Tirrell reports which companies investors should watch. Also, Les Funtleyder, ESquared Asset Management, shares his view.

  • Hungover? Pedialyte wants your business Wednesday, 13 May 2015 | 2:51 PM ET
    Pedialyte a hangover cure? The company increases its focus on adult consumers.

    Pedialyte is going after a new market, and they don't have a bedtime...

Contact Biotech and Pharma

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

 

  • Dan Mangan is a reporter covering health care for CNBC.com.

  • Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.

  • Bertha Coombs

    Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.